Remove 2023 Remove Conditions Remove Data
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Advantages and disadvantages Traditional topicals including water-based lotions and creams and oil-based balms and salves offer a quick onset time, no psychoactivity, and the potential to treat not only aches, pains, and inflammation, but also skin conditions like psoriasis and eczema. So what do the studies say? Clinical benefits?

Topical 179
article thumbnail

Illinois releases Cannabis Report FY2024 (IDFPR portion)

Illinois News Joint

The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Work with remaining conditional license-holders to transition to fully operational dispensaries serving both medical patients and adult use customers. Find detailed information about this topic here.)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. A 2022 meta-analysis of 23 studies published in Clinical Pharmacology & Therapeutics found that therapeutic effects plateau at relatively low doses for most conditions.

article thumbnail

The Fall of South Dakota’s Cannabis Industry

Veriheal

Currently, with t he required certificate from a certified medical practitioner due to a qualifying condition, medical marijuana possession for patients is allowed in South Dakota. In the winter of 2023, according to South Dakota’s Data and Statistics report , close to 13,000 medical marijuana cardholders were registered.

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Drug company Lykos Therapeutics, which had filed the new drug application for MDMA therapy , was informed by the US Food and Drug Administration (FDA) that the data submitted was insufficient to receive approval, requesting that the company conduct an additional Phase 3 trial to further test the safety and efficacy of the drug.

article thumbnail

Veriheal’s 2023 Innovation In Cannabis Scholarship Winners

Veriheal

As we reflect on the success of the 2022 recipients, we are thrilled to introduce the exceptional winners of the 2023 scholarship. Without further to do, here are the bright and brilliant recipients of the 2023 Innovation in Cannabis Scholarship. Veriheal recognizes the financial challenges students face in pursuing higher education.

article thumbnail

Wearables data: CBD+CBN+THC can support deeper sleep

The Cannigma

1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant.

Sleep 105